Business Description
ICU Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US44930G1076
Description
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.79 | |||||
| Debt-to-EBITDA | 6.82 | |||||
| Interest Coverage | 0.31 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.15 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.6 | |||||
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year FCF Growth Rate | -228.4 | |||||
| 3-Year Book Growth Rate | 9.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 16.49 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.13 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.78 | |||||
| 9-Day RSI | 55.08 | |||||
| 14-Day RSI | 53.91 | |||||
| 6-1 Month Momentum % | 36.03 | |||||
| 12-1 Month Momentum % | 20.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 146.9 | |||||
| Days Sales Outstanding | 31.44 | |||||
| Days Payable | 46.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.27 | |||||
| Operating Margin % | 1.06 | |||||
| Net Margin % | -2 | |||||
| ROE % | -2.2 | |||||
| ROA % | -1.01 | |||||
| ROIC % | 0.39 | |||||
| ROC (Joel Greenblatt) % | 0.54 | |||||
| ROCE % | 0.16 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 26.33 | |||||
| Shiller PE Ratio | 61.9 | |||||
| PS Ratio | 1.96 | |||||
| PB Ratio | 2.16 | |||||
| EV-to-EBIT | 907.61 | |||||
| EV-to-Forward-EBIT | 551.08 | |||||
| EV-to-EBITDA | 24.8 | |||||
| EV-to-Forward-EBITDA | 25.47 | |||||
| EV-to-Revenue | 2.63 | |||||
| EV-to-Forward-Revenue | 2.54 | |||||
| EV-to-FCF | -55.3 | |||||
| Price-to-Projected-FCF | 2.1 | |||||
| Price-to-Median-PS-Value | 0.54 | |||||
| Earnings Yield (Greenblatt) % | 0.11 | |||||
| Forward Rate of Return (Yacktman) % | 13.83 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ICUI
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
ICU Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,305.524 | ||
| EPS (TTM) ($) | -1.92 | ||
| Beta | 0.69 | ||
| Volatility % | 37.29 | ||
| 14-Day RSI | 53.91 | ||
| 14-Day ATR ($) | 5.520995 | ||
| 20-Day SMA ($) | 186.5125 | ||
| 12-1 Month Momentum % | 20.75 | ||
| 52-Week Range ($) | 128.9 - 212.43 | ||
| Shares Outstanding (Mil) | 24.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ICU Medical Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
ICU Medical Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ICU Medical Inc Frequently Asked Questions
What is ICU Medical Inc(ICUI)'s stock price today?
The current price of ICUI is $188.80. The 52 week high of ICUI is $212.43 and 52 week low is $128.90.
When is next earnings date of ICU Medical Inc(ICUI)?
The next earnings date of ICU Medical Inc(ICUI) is 2023-08-08 Est..
Does ICU Medical Inc(ICUI) pay dividends? If so, how much?
ICU Medical Inc(ICUI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers